Robins Jason

Jason Robins sold 666,651 shares for $28.3M at DraftKings; holdings drop 16.7% to 3.34M shares

Jason Robins executed 3 separate sales totaling 666,651 shares for $28,281,278.95 on 2025-02-25, reducing his post-transaction holdings to 3,336,195 shares (a 16.7% reduction from 4,002,846 shares held before). The blended average sale price of $42.42 sits near the current price of $42.51, suggesting recent execution. At DKNG specifically, Robins' prior 4 measurable sales show 1 of 4 achieved negative 90-day returns (well-timed for a seller), indicating mixed historical timing at this ticker. His cross-ticker track record across 20 prior sells shows an average 90-day return of +6.5% with a 27.78% well-timed rate, meaning the stock has typically risen after his sales. The company remains unprofitable (net income of $-293,688,000.00 for the latest fiscal year) despite strong revenue growth of +30.1% year-over-year, creating a tension between operational scale and current earnings power that warrants attention to the reasoning behind this substantial reduction in his stake.

Robins Jason sold 200,000 shares of DKNG at $45.00 on 2025-02-12 ($9.0M); stock now at $53.49.

This sale represents a material reduction of 6.9% from Robins Jason's prior holdings of 2,878,613 shares, executed at $45.00—well below the current price of $53.49 and the 52-week high of $53.49. The timing is notable: while DKNG has surged 38.2% in the prior 30 days and 34.3% over 90 days, his prior trades at this same ticker show mixed timing—3 of 5 prior sales (in August and early May 2024) were well-timed in the 90-day window (stock subsequently fell), but 2 prior May sales were poorly timed (stock rose 20%+). At the open-market level, his cross-ticker track record shows positive average 90-day returns of 8.2% after sells, meaning he has historically sold before rallies rather than declines. Against that backdrop, this $9.0M sale into a strong momentum period warrants attention, particularly given the company remains unprofitable (net income of $-293.7M over its most recent full fiscal year) despite 30.1% annual revenue growth.

DraftKings exec Jason Robins sells 200,000 shares for $7.1M; 4 of 4 prior same-ticker sales were well-timed.

Robins sold 200,000 shares (2 separate transactions at $35.20 and $35.84 on 2024-08-21) for a combined $7,050,584.96, reducing his holdings by 6.9% to 2.68M shares post-transaction. His track record across all tickers shows a 90d well-timed rate of 27.78%, indicating modest accuracy in timing sells. More notably, at DKNG specifically, Robins has completed 4 prior measurable sales (2024-04-22, 2024-05-08, 2024-05-21, 2024-05-21), and all 4 exhibited negative 90-day returns—meaning he sold before price declines every time at this ticker. The current stock price of $36.37 is 25.3% below the 52-week high of $48.68, having fallen 10.9% over the past 90 days. DKNG posted strong recent fundamentals with $1.1B quarterly revenue and +63.6% annual growth, though the company remains unprofitable on a full-year basis, suggesting macro or operational headwinds may justify the insider's exit pattern despite solid topline momentum.

Robins sold 200,000 DKNG shares at $30.72; stock down 37.7% from 52-week high, down 29.9% in 90 days.

Robins Jason sold 200,000 shares of DraftKings at $30.72 on 2024-08-08, reducing holdings by 6.9% to 2.68M shares. The sale occurred as DKNG has declined substantially—37.7% from its 52-week high of $48.68 and 29.9% over the past 90 days. At DKNG specifically, Robins' prior three measurable sales (on 2024-05-08, 2024-04-22 dated trades) were well-timed at the 90-day mark, with the May 8 sale followed by a 26.5% decline. This August transaction follows that same pattern of selling into weakness. The company has grown revenue 63.6% year-over-year but reported net income of $63.8M against $1.1B quarterly revenue—a notable profitability margin that provides some context for the extended stock decline, though fundamentals alone do not explain the magnitude of recent weakness.